What is genomic tumour profiling done with?

A laboratory extracts genetic material from a tumour sample, often tissue collected during a biopsy or operation. In some situations, a blood sample may be suitable for looking for tumour-derived genetic material. The laboratory checks selected genes or broader groups of genes for changes that can help describe the tumour's biology.

Many laboratories use next-generation sequencing, which can read multiple genetic regions in one testing process. The report may identify a change linked with a possible treatment option, a change that helps classify the tumour, or a result with uncertain meaning. A finding does not automatically predict how an individual will respond.

Ask whether stored tissue can be used, whether a new sample is needed, and whether the sample contains enough tumour material. Discuss how the result could affect treatment choices, the expected reporting time, and whether an inherited genetic assessment is separate from tumour testing. Keep a copy of the final report for future consultations.

Genomic profiling itself does not usually create a new physical symptom because it is performed on collected material. Seek care for problems caused by the biopsy or blood draw, such as persistent bleeding, increasing pain, fever, spreading redness, or drainage. Urgent symptoms include fainting, heavy bleeding, or severe breathing difficulty.

Ask which genes are being assessed, what a positive, negative, or uncertain result could mean, whether the test may identify an option or trial, and who will explain the report.